Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate
Open Access
- 18 March 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 18 (5), 1013-1019
- https://doi.org/10.1038/sj.leu.2403343
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell TransplantationBone Marrow Transplantation, 2000
- Estimation of failure probabilities in the presence of competing risks: new representations of old estimatorsStatistics in Medicine, 1999
- The Highest Leukaemia-Free Survival After Allogeneic Bone Marrow Transplantation is Seen in Patients with Grade I Acute Graft-Versus-Host DiseaseLeukemia & Lymphoma, 1996
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]Blood, 1989
- Analysis of survival by tumor response.Journal of Clinical Oncology, 1983
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseThe New England Journal of Medicine, 1981
- Chronic graft-versus-host syndrome in manAmerican Journal Of Medicine, 1980
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsThe New England Journal of Medicine, 1979
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974